Cargando…

Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population

INTRODUCTION: Sleep disorders and short sleep duration are common symptoms among people with diabetes. However, the evidence is limited about the associations of post-challenge hyperglycemia and sleep quality or quantity with all-cause mortality in the US general population. RESEARCH DESIGN AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Kosuke, Semba, Eriko, Yamakawa, Tadashi, Terauchi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344283/
https://www.ncbi.nlm.nih.gov/pubmed/34353879
http://dx.doi.org/10.1136/bmjdrc-2020-002047
_version_ 1783734458924400640
author Inoue, Kosuke
Semba, Eriko
Yamakawa, Tadashi
Terauchi, Yasuo
author_facet Inoue, Kosuke
Semba, Eriko
Yamakawa, Tadashi
Terauchi, Yasuo
author_sort Inoue, Kosuke
collection PubMed
description INTRODUCTION: Sleep disorders and short sleep duration are common symptoms among people with diabetes. However, the evidence is limited about the associations of post-challenge hyperglycemia and sleep quality or quantity with all-cause mortality in the US general population. RESEARCH DESIGN AND METHODS: Our study included 8795 adults from the National Health and Nutrition Examination Survey 2005–2014. Mortality data were ascertained through 2015. Multivariable Cox proportional-hazards models were used to estimate adjusted HRs (aHRs) for all-cause mortality according to 2-hour plasma glucose levels during the 75 g oral glucose tolerance test—normal glucose tolerance (NGT), <140 mg/dL; impaired glucose tolerance (IGT), 140–199 mg/dL; and diabetes, ≥200 mg/dL. We then examined the associations of glucose tolerance status and self-reported physician-diagnosed sleep disorders (yes vs no) or sleep duration (<7 vs ≥7 hours) with all-cause mortality. RESULTS: During follow-up (median, 5.6 years), the diabetes group had a higher risk of all-cause mortality compared with the NGT group (aHR (95% CI)=1.93 (1.41 to 2.64)), but not the IGT group (aHR (95% CI)=1.19 (0.90 to 1.59)). When we categorized participants according to glucose tolerance status and sleep disorders, the IGT group with sleep disorders had a higher risk of all-cause mortality (aHR (95% CI)=2.03 (1.24 to 3.34)) compared with the NGT group without sleep disorders. Both diabetes groups with and without sleep disorders also showed high mortality risks. The results were consistent when we used sleep duration instead of sleep disorders. CONCLUSIONS: Using the most updated US national data, we found a high risk of all-cause mortality among individuals with IGT having sleep disorders or short sleep duration as well as those with diabetes. Future investigations are needed to identify whether and what kind of sleep management is beneficial for people with impaired glucose metabolism to prevent early death.
format Online
Article
Text
id pubmed-8344283
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-83442832021-08-20 Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population Inoue, Kosuke Semba, Eriko Yamakawa, Tadashi Terauchi, Yasuo BMJ Open Diabetes Res Care Epidemiology/Health services research INTRODUCTION: Sleep disorders and short sleep duration are common symptoms among people with diabetes. However, the evidence is limited about the associations of post-challenge hyperglycemia and sleep quality or quantity with all-cause mortality in the US general population. RESEARCH DESIGN AND METHODS: Our study included 8795 adults from the National Health and Nutrition Examination Survey 2005–2014. Mortality data were ascertained through 2015. Multivariable Cox proportional-hazards models were used to estimate adjusted HRs (aHRs) for all-cause mortality according to 2-hour plasma glucose levels during the 75 g oral glucose tolerance test—normal glucose tolerance (NGT), <140 mg/dL; impaired glucose tolerance (IGT), 140–199 mg/dL; and diabetes, ≥200 mg/dL. We then examined the associations of glucose tolerance status and self-reported physician-diagnosed sleep disorders (yes vs no) or sleep duration (<7 vs ≥7 hours) with all-cause mortality. RESULTS: During follow-up (median, 5.6 years), the diabetes group had a higher risk of all-cause mortality compared with the NGT group (aHR (95% CI)=1.93 (1.41 to 2.64)), but not the IGT group (aHR (95% CI)=1.19 (0.90 to 1.59)). When we categorized participants according to glucose tolerance status and sleep disorders, the IGT group with sleep disorders had a higher risk of all-cause mortality (aHR (95% CI)=2.03 (1.24 to 3.34)) compared with the NGT group without sleep disorders. Both diabetes groups with and without sleep disorders also showed high mortality risks. The results were consistent when we used sleep duration instead of sleep disorders. CONCLUSIONS: Using the most updated US national data, we found a high risk of all-cause mortality among individuals with IGT having sleep disorders or short sleep duration as well as those with diabetes. Future investigations are needed to identify whether and what kind of sleep management is beneficial for people with impaired glucose metabolism to prevent early death. BMJ Publishing Group 2021-08-05 /pmc/articles/PMC8344283/ /pubmed/34353879 http://dx.doi.org/10.1136/bmjdrc-2020-002047 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology/Health services research
Inoue, Kosuke
Semba, Eriko
Yamakawa, Tadashi
Terauchi, Yasuo
Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
title Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
title_full Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
title_fullStr Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
title_full_unstemmed Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
title_short Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
title_sort associations of impaired glucose tolerance and sleep disorders with mortality among the us general population
topic Epidemiology/Health services research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344283/
https://www.ncbi.nlm.nih.gov/pubmed/34353879
http://dx.doi.org/10.1136/bmjdrc-2020-002047
work_keys_str_mv AT inouekosuke associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation
AT sembaeriko associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation
AT yamakawatadashi associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation
AT terauchiyasuo associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation